The pediatric neurology device market size has grown strongly in recent years. It will grow from $2.65 billion in 2025 to $2.8 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising incidence of pediatric neurological disorders and developmental conditions, growing availability of eeg and neurodiagnostic assessment services, early adoption of neurosurgery and csf shunt procedures in tertiary hospitals, expansion of pediatric stroke and seizure management programs, increasing investment in pediatric neurology infrastructure in specialty centers.
The pediatric neurology device market size is expected to see strong growth in the next few years. It will grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing demand for neurostimulation and vagal nerve stimulation therapies in children, rising utilization of interventional neurology devices for minimally invasive treatment, increasing procedure volumes for hydrocephalus and oncology-related neurology care, expanding access to pediatric neurology services in emerging regions, rising focus on early diagnosis and long-term neurological outcome improvement. Major trends in the forecast period include rising adoption of advanced neurostimulation and neuromodulation devices in pediatric neurology, increasing utilization of interventional neurology devices for complex pediatric stroke and vascular disorders, growing preference for minimally invasive neurosurgical and navigation-assisted procedures, expansion of pediatric cerebrospinal fluid management solutions for hydrocephalus care, increasing use of pediatric eeg monitoring and neurodiagnostic systems in clinical evaluation.
The anticipated increase in the prevalence of autism in children is expected to drive the growth of the pediatric neurology devices market. Autism, a developmental condition affecting how individuals perceive and interact with others, presents challenges in communication and social interaction. Pediatric neurology devices play a crucial role in the diagnosis and treatment of children with autism, contributing to improvements in their quality of life, social skills, and management of cognitive and behavioral symptoms. In March 2023, data from the Centers for Disease Control and Prevention (CDC) revealed that, according to the Autism and Developmental Disabilities Monitoring (ADDM) Network, one in 36 (2.8%) 8-year-old children in 11 communities across the United States were identified with autism spectrum disorder (ASD). Consequently, the rising prevalence of autism in children is a key factor driving the growth of the pediatric neurology devices market.
The rising number of pediatric patients is expected to drive the growth of the pediatric neurology device market in the coming years. A pediatric patient is defined as a minor, generally under the age of 15 or 21, depending on national regulations. Pediatric neurology devices are specifically developed to address the distinct requirements of infants, children, and adolescents, whose neurological systems are still in critical stages of growth and development. Pediatric neurology devices support the diagnosis and management of a range of neurological conditions in children, including stroke, seizures, hydrocephalus, and pediatric oncology. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based intergovernmental organization, the number of children under the age of 18 in care increased to 71 per 100,000 in 2023, compared to 70 per 100,000 in 2022. During the same year, rates were significantly higher among older children, reaching 168 per 100,000 for those aged 16-17 and 76 per 100,000 for children aged 10-15. Therefore, the growing pediatric population is contributing to the expansion of the pediatric neurology device market.
Major companies operating in the pediatric neurology market are prioritizing technological advancements, such as AI-enabled, point-of-care EEG systems, to support rapid identification and diagnosis of electrographic seizures in children, enabling timely clinical intervention and improved neurological outcomes. AI-powered point-of-care EEG systems combine real-time signal processing, algorithm-driven seizure detection, and user-friendly headband designs to deliver actionable bedside insights, helping clinicians reduce treatment delays and lower the risk of brain injury in pediatric patients. For instance, in April 2025, Ceribell, Inc., a US-based medical technology company, obtained FDA clearance for its Clarity algorithm for patients aged 1 year and older. When used with Ceribell EEG headbands, the algorithm enables fast bedside detection of non-convulsive seizures in children, addresses the widest pediatric age range covered by seizure detection technology to date, and utilizes EEG data from more than 1,700 pediatric patients to provide dependable, real-time diagnostic support in emergency and critical care environments.
Major companies operating in the pediatric neurology device market are Johnson & Johnson Co, Abbott Laboratories, Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips NV, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Masimo Corporation, KARL STORZ SE & Co. KG, Nihon Kohden Corporation, Integra LifeSciences Holdings Corp., Elekta AB, LivaNova PLC, Natus Medical Incorporated, Allengers Medical Systems Limited, Compumedics Limited, Cadwell Industries Inc., Spiegelberg GmbH & Co. KG.
North America was the largest region in the pediatric neurology device market in 2025. The regions covered in the pediatric neurology device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric neurology device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric neurology device market by increasing import costs for precision electronics, imaging hardware, neurostimulation components, and catheter-based interventional systems, which has raised manufacturing and procurement expenses across neurostimulation, neurosurgery, interventional neurology, and csf management segments. The effects are more pronounced in North America, Europe, and Asia-Pacific markets that depend on cross-border sourcing for pediatric eeg systems, shunts, navigation platforms, and vascular intervention devices used in hospitals and ambulatory surgery centers. These higher landed costs have contributed to pricing pressure and delayed equipment upgrades in cost-sensitive facilities; however, tariffs are also encouraging regional assembly, localized supplier ecosystems, and strategic partnerships that support selective positive outcomes for domestic production capabilities.
The pediatric neurology device market research report is one of a series of new reports that provides pediatric neurology device market statistics, including pediatric neurology device industry global market size, regional shares, competitors with a pediatric neurology device market share, detailed pediatric neurology device market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric neurology device industry. This pediatric neurology device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric neurology devices are medical instruments specifically designed to aid in the diagnosis, prevention, and treatment of various neurological disorders in children. These devices are utilized by pediatric neurologists and other medical professionals to address the complete spectrum of neurological disorders in pediatric patients.
The primary types of pediatric neurology devices include neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Neurostimulation devices are medical equipment that alters the activity of the nervous system through electrical or magnetic stimulation. They are employed in the treatment of various conditions such as stroke, seizures, hydrocephalus, and oncology. The range of services and treatments associated with these devices includes electroencephalogram, intrathecal baclofen therapy, neurological evaluations, vagal nerve stimulation, among others. These devices are utilized by various end users, including hospitals, ambulatory surgery centers, and other healthcare facilities.
The pediatric neurology device market consists of sales of portable and wearable neurology devices, intracranial pressure (ICP) monitors, cerebral oximeters, and infusion pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pediatric neurology device market size is expected to see strong growth in the next few years. It will grow to $3.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing demand for neurostimulation and vagal nerve stimulation therapies in children, rising utilization of interventional neurology devices for minimally invasive treatment, increasing procedure volumes for hydrocephalus and oncology-related neurology care, expanding access to pediatric neurology services in emerging regions, rising focus on early diagnosis and long-term neurological outcome improvement. Major trends in the forecast period include rising adoption of advanced neurostimulation and neuromodulation devices in pediatric neurology, increasing utilization of interventional neurology devices for complex pediatric stroke and vascular disorders, growing preference for minimally invasive neurosurgical and navigation-assisted procedures, expansion of pediatric cerebrospinal fluid management solutions for hydrocephalus care, increasing use of pediatric eeg monitoring and neurodiagnostic systems in clinical evaluation.
The anticipated increase in the prevalence of autism in children is expected to drive the growth of the pediatric neurology devices market. Autism, a developmental condition affecting how individuals perceive and interact with others, presents challenges in communication and social interaction. Pediatric neurology devices play a crucial role in the diagnosis and treatment of children with autism, contributing to improvements in their quality of life, social skills, and management of cognitive and behavioral symptoms. In March 2023, data from the Centers for Disease Control and Prevention (CDC) revealed that, according to the Autism and Developmental Disabilities Monitoring (ADDM) Network, one in 36 (2.8%) 8-year-old children in 11 communities across the United States were identified with autism spectrum disorder (ASD). Consequently, the rising prevalence of autism in children is a key factor driving the growth of the pediatric neurology devices market.
The rising number of pediatric patients is expected to drive the growth of the pediatric neurology device market in the coming years. A pediatric patient is defined as a minor, generally under the age of 15 or 21, depending on national regulations. Pediatric neurology devices are specifically developed to address the distinct requirements of infants, children, and adolescents, whose neurological systems are still in critical stages of growth and development. Pediatric neurology devices support the diagnosis and management of a range of neurological conditions in children, including stroke, seizures, hydrocephalus, and pediatric oncology. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based intergovernmental organization, the number of children under the age of 18 in care increased to 71 per 100,000 in 2023, compared to 70 per 100,000 in 2022. During the same year, rates were significantly higher among older children, reaching 168 per 100,000 for those aged 16-17 and 76 per 100,000 for children aged 10-15. Therefore, the growing pediatric population is contributing to the expansion of the pediatric neurology device market.
Major companies operating in the pediatric neurology market are prioritizing technological advancements, such as AI-enabled, point-of-care EEG systems, to support rapid identification and diagnosis of electrographic seizures in children, enabling timely clinical intervention and improved neurological outcomes. AI-powered point-of-care EEG systems combine real-time signal processing, algorithm-driven seizure detection, and user-friendly headband designs to deliver actionable bedside insights, helping clinicians reduce treatment delays and lower the risk of brain injury in pediatric patients. For instance, in April 2025, Ceribell, Inc., a US-based medical technology company, obtained FDA clearance for its Clarity algorithm for patients aged 1 year and older. When used with Ceribell EEG headbands, the algorithm enables fast bedside detection of non-convulsive seizures in children, addresses the widest pediatric age range covered by seizure detection technology to date, and utilizes EEG data from more than 1,700 pediatric patients to provide dependable, real-time diagnostic support in emergency and critical care environments.
Major companies operating in the pediatric neurology device market are Johnson & Johnson Co, Abbott Laboratories, Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips NV, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Masimo Corporation, KARL STORZ SE & Co. KG, Nihon Kohden Corporation, Integra LifeSciences Holdings Corp., Elekta AB, LivaNova PLC, Natus Medical Incorporated, Allengers Medical Systems Limited, Compumedics Limited, Cadwell Industries Inc., Spiegelberg GmbH & Co. KG.
North America was the largest region in the pediatric neurology device market in 2025. The regions covered in the pediatric neurology device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric neurology device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric neurology device market by increasing import costs for precision electronics, imaging hardware, neurostimulation components, and catheter-based interventional systems, which has raised manufacturing and procurement expenses across neurostimulation, neurosurgery, interventional neurology, and csf management segments. The effects are more pronounced in North America, Europe, and Asia-Pacific markets that depend on cross-border sourcing for pediatric eeg systems, shunts, navigation platforms, and vascular intervention devices used in hospitals and ambulatory surgery centers. These higher landed costs have contributed to pricing pressure and delayed equipment upgrades in cost-sensitive facilities; however, tariffs are also encouraging regional assembly, localized supplier ecosystems, and strategic partnerships that support selective positive outcomes for domestic production capabilities.
The pediatric neurology device market research report is one of a series of new reports that provides pediatric neurology device market statistics, including pediatric neurology device industry global market size, regional shares, competitors with a pediatric neurology device market share, detailed pediatric neurology device market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric neurology device industry. This pediatric neurology device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric neurology devices are medical instruments specifically designed to aid in the diagnosis, prevention, and treatment of various neurological disorders in children. These devices are utilized by pediatric neurologists and other medical professionals to address the complete spectrum of neurological disorders in pediatric patients.
The primary types of pediatric neurology devices include neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Neurostimulation devices are medical equipment that alters the activity of the nervous system through electrical or magnetic stimulation. They are employed in the treatment of various conditions such as stroke, seizures, hydrocephalus, and oncology. The range of services and treatments associated with these devices includes electroencephalogram, intrathecal baclofen therapy, neurological evaluations, vagal nerve stimulation, among others. These devices are utilized by various end users, including hospitals, ambulatory surgery centers, and other healthcare facilities.
The pediatric neurology device market consists of sales of portable and wearable neurology devices, intracranial pressure (ICP) monitors, cerebral oximeters, and infusion pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pediatric Neurology Device Market Characteristics
3. Pediatric Neurology Device Market Supply Chain Analysis
4. Global Pediatric Neurology Device Market Trends and Strategies
5. Pediatric Neurology Device Market Analysis of End Use Industries
7. Global Pediatric Neurology Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pediatric Neurology Device Total Addressable Market (TAM) Analysis for the Market
9. Pediatric Neurology Device Market Segmentation
10. Pediatric Neurology Device Market Regional and Country Analysis
11. Asia-Pacific Pediatric Neurology Device Market
12. China Pediatric Neurology Device Market
13. India Pediatric Neurology Device Market
14. Japan Pediatric Neurology Device Market
15. Australia Pediatric Neurology Device Market
16. Indonesia Pediatric Neurology Device Market
17. South Korea Pediatric Neurology Device Market
18. Taiwan Pediatric Neurology Device Market
19. South East Asia Pediatric Neurology Device Market
20. Western Europe Pediatric Neurology Device Market
21. UK Pediatric Neurology Device Market
22. Germany Pediatric Neurology Device Market
23. France Pediatric Neurology Device Market
24. Italy Pediatric Neurology Device Market
25. Spain Pediatric Neurology Device Market
26. Eastern Europe Pediatric Neurology Device Market
27. Russia Pediatric Neurology Device Market
28. North America Pediatric Neurology Device Market
29. USA Pediatric Neurology Device Market
30. Canada Pediatric Neurology Device Market
31. South America Pediatric Neurology Device Market
32. Brazil Pediatric Neurology Device Market
33. Middle East Pediatric Neurology Device Market
34. Africa Pediatric Neurology Device Market
36. Pediatric Neurology Device Market Competitive Landscape and Company Profiles
37. Pediatric Neurology Device Market Other Major and Innovative Companies
40. Pediatric Neurology Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pediatric Neurology Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pediatric neurology device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pediatric neurology device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric neurology device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Neurostimulation Devices; Neurosurgery Devices; Interventional Neurology Devices; Cerebrospinal Fluid Management Devices; Other Types2) By Condition: Stroke; Seizures; Hydrocephalus; Oncology; Other Conditions
3) By Service And Treatment: Electroencephalogram; Intrathecal Baclofen Therapy; Neurological Evaluations; Vagal Nerve Stimulation; Other Services And Treatments
4) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Neurostimulation Devices: Deep Brain Stimulation (DBS) Devices; Transcranial Magnetic Stimulation (TMS) Devices; Vagus Nerve Stimulation (VNS) Devices; Spinal Cord Stimulation (SCS) Devices2) By Neurosurgery Devices: Craniotomy Instruments; Surgical Navigation Systems; Brain Tumor Resection Devices; Endoscopic Neurosurgical Devices; Intracranial Pressure Monitoring Systems
3) By Interventional Neurology Devices: Catheters for Neurovascular Intervention; Neurovascular Stents; Embolization Devices; Thrombectomy Devices; Intracranial Aneurysm Coiling Systems
4) By Cerebrospinal Fluid Management Devices: External Ventricular Drainage Systems; Lumbar Drainage Systems
5) By Other Types: Pediatric EEG (Electroencephalogram) Devices; Pediatric MRI and CT Scanners; Pediatric Neurology Monitoring Systems; Neurodiagnostic Devices for Pediatrics
Companies Mentioned: Johnson & Johnson Co; Abbott Laboratories; Medtronic Plc; Siemens Healthineers AG; Koninklijke Philips NV; Stryker Corporation; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Masimo Corporation; KARL STORZ SE & Co. KG; Nihon Kohden Corporation; Integra LifeSciences Holdings Corp.; Elekta AB; LivaNova PLC; Natus Medical Incorporated; Allengers Medical Systems Limited; Compumedics Limited; Cadwell Industries Inc.; Spiegelberg GmbH & Co. KG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pediatric Neurology Device market report include:- Johnson & Johnson Co
- Abbott Laboratories
- Medtronic Plc
- Siemens Healthineers AG
- Koninklijke Philips NV
- Stryker Corporation
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- Masimo Corporation
- KARL STORZ SE & Co. KG
- Nihon Kohden Corporation
- Integra LifeSciences Holdings Corp.
- Elekta AB
- LivaNova PLC
- Natus Medical Incorporated
- Allengers Medical Systems Limited
- Compumedics Limited
- Cadwell Industries Inc.
- Spiegelberg GmbH & Co. KG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.8 Billion |
| Forecasted Market Value ( USD | $ 3.45 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
